ENZY

Enzymotec Ltd
ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

34 hedge funds and large institutions have $57.2M invested in Enzymotec Ltd in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 34 → 34 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

18% less capital inflows, than outflows

Capital inflows: $2.29M | Capital outflows: $2.8M

Holders
34
Holders Change
–
Holders Change %
0%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
13
Reduced
13
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TM
Tiger Management
New York
+$803K
2
Millennium Management
Millennium Management
New York
+$572K
3
JHIU
Janus Henderson Investors US
Colorado
+$334K
4
State Street
State Street
Massachusetts
+$153K
5
Renaissance Technologies
Renaissance Technologies
New York
+$139K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.74M
2
LCM
Laurion Capital Management
New York
-$282K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$160K
4
PC
Paulson & Co
New York
-$146K
5
CAM
ClariVest Asset Management
California
-$90K

ENZY Hedge Fund Activity: Q3 2016 in Review

34 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q3 2016, worth a combined $57.2M — down 15% from $67.3M a quarter earlier.

Fund positioning in ENZY was balanced in Q3 2016: 2 funds opened new positions, 2 closed out, 13 added to existing stakes and 13 trimmed.

The largest buyer was Tiger Management, adding an estimated $803K. The largest seller was Goldman Sachs, cutting an estimated $1.74M.

  • 34 institutional investors held Enzymotec Ltd (ENZY) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $57.2M of Enzymotec Ltd stock for Q3 2016, down 15% quarter-over-quarter.
  • 2 funds opened new Enzymotec Ltd positions in Q3 2016 and 2 closed out, a net change of 0 holders.
  • The largest Enzymotec Ltd buyer in Q3 2016 was Tiger Management, an estimated $803K added.
  • The largest Enzymotec Ltd seller in Q3 2016 was Goldman Sachs, an estimated $1.74M sold.

Based on aggregated 13F filings for Q3 2016.